Literature DB >> 19903417

Do COX-2 inhibitors reduce metachronous cancer development?

Joseph R Pisegna1.   

Abstract

Entities:  

Year:  2009        PMID： 19903417     DOI： 10.1007/s11894-009-0066-7

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN： 1522-8037


× No keyword cloud information.
  11 in total

1.  The changing trends of the incidence of gastric cancer after Helicobacter pylori eradication in Shandong area.

Authors:  Li Ya Zhou; San Ren Lin; Shi Gang Ding; Xue Biao Huang; Li Zhang; Ling Mei Meng; Rong Li Cui; Jin Zhu
Journal:  Chin J Dig Dis       Date:  2005

2.  Eradication diminishes enhancing effects of Helicobacter pylori infection on glandular stomach carcinogenesis in Mongolian gerbils.

Authors:  N Shimizu; Y Ikehara; K Inada; H Nakanishi; T Tsukamoto; K Nozaki; M Kaminishi; S Kuramoto; A Sugiyama; T Katsuyama; M Tatematsu
Journal:  Cancer Res       Date:  2000-03-15       Impact factor: 12.701

3.  Inhibitory effect of etodolac, a selective cyclooxygenase-2 inhibitor, on stomach carcinogenesis in Helicobacter pylori-infected Mongolian gerbils.

Authors:  Hirohito Magari; Yasuhito Shimizu; Ken-ichi Inada; Shotaro Enomoto; Tatsuji Tomeki; Kimihiko Yanaoka; Hideyuki Tamai; Kenji Arii; Hiroya Nakata; Masashi Oka; Hirotoshi Utsunomiya; Yutaka Tsutsumi; Tetsuya Tsukamoto; Masae Tatematsu; Masao Ichinose
Journal:  Biochem Biophys Res Commun       Date:  2005-08-26       Impact factor: 3.575

4.  Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type.

Authors:  R Takenaka; H Okada; J Kato; C Makidono; S Hori; Y Kawahara; M Miyoshi; E Yumoto; A Imagawa; T Toyokawa; K Sakaguchi; Y Shiratori
Journal:  Aliment Pharmacol Ther       Date:  2007-04-01       Impact factor: 8.171

5.  Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice.

Authors:  Xun Cai; Jane Carlson; Calin Stoicov; Hanchen Li; Timothy C Wang; JeanMarie Houghton
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

6.  Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases.

Authors:  Susumu Take; Motowo Mizuno; Kuniharu Ishiki; Yasuhiro Nagahara; Tomowo Yoshida; Kenji Yokota; Keiji Oguma
Journal:  J Gastroenterol       Date:  2007-01       Impact factor: 7.527

7.  Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.

Authors:  Wei-cheng You; Linda M Brown; Lian Zhang; Ji-you Li; Mao-lin Jin; Yun-shen Chang; Jun-ling Ma; Kai-feng Pan; Wei-dong Liu; Yuanreng Hu; Susan Crystal-Mansour; David Pee; William J Blot; Joseph F Fraumeni; Guang-wei Xu; Mitchell H Gail
Journal:  J Natl Cancer Inst       Date:  2006-07-19       Impact factor: 13.506

8.  Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils.

Authors:  Koji Nozaki; Nobuyuki Shimizu; Yuzuru Ikehara; Manami Inoue; Tetsuya Tsukamoto; Ken-ichi Inada; Harunari Tanaka; Toshiko Kumagai; Michio Kaminishi; Masae Tatematsu
Journal:  Cancer Sci       Date:  2003-03       Impact factor: 6.716

9.  The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer.

Authors:  Keiji Ogura; Yoshihiro Hirata; Ayako Yanai; Wataru Shibata; Tomoya Ohmae; Yuzo Mitsuno; Shin Maeda; Hirotsugu Watabe; Yutaka Yamaji; Makoto Okamoto; Haruhiko Yoshida; Takao Kawabe; Masao Omata
Journal:  J Clin Gastroenterol       Date:  2008-03       Impact factor: 3.062

10.  Celecoxib inhibits Cdx2 expression and prevents gastric cancer in Helicobacter pylori-infected Mongolian gerbils.

Authors:  Seiji Futagami; Kenji Suzuki; Tetsuro Hiratsuka; Tomotaka Shindo; Tatsuhiko Hamamoto; Atsushi Tatsuguchi; Nobue Ueki; Yoko Shinji; Masanori Kusunoki; Ken Wada; Kazumasa Miyake; Katya Gudis; Taku Tsukui; Choitsu Sakamoto
Journal:  Digestion       Date:  2007-03-06       Impact factor: 3.216
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.